Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam
Crossref DOI link: https://doi.org/10.1007/s40121-020-00297-3
Published Online: 2020-06-30
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sánchez-García, Miguel
Hammond, Jennifer
Yan, Jean Li
Kantecki, Michal
Ansari, Wajeeha
Dryden, Matthew
Funding for this research was provided by:
Pfizer
Article History
Received: 31 December 2019
First Online: 30 June 2020